Novo Nordisk's pricing strategies in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of value gouging, mentioning the stark distinction in between U.S. selling prices and people in Europe and copyright.Rybelsus and copyright brought on thyroid tumors in mice and rats throughout animal reports. It